UCB-4470

N/A

Report date: 2025/01/26 16:35:45

Base Information

Drug NameUCB-4470
Drug Alias Nameanti-FcRn inhibitor (UCB Pharma/King's College London)UCB-4470
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIgG receptor FcRn large subunit p51 inhibitors
TargetsIgG receptor FcRn large subunit p51
Therapy Area/IndicationsThrombosisHereditary Central Nervous System Demyelinating Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKing'S College London
China Registration ClassN/A

Develop Information

Active CompaniesKing'S College LondonUcb Pharma Sa
Inactive CompaniesN/A
Active IndicationsThrombosisHereditary Central Nervous System Demyelinating Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A